Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in HER2 Negative Breast Cancer
NCT05103644Phase 3Unknown
- Sponsor
- Beni Suef University
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in breast cancer, sponsored by Beni Suef University. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05103644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05103644.